... (Osaka) 79 Hydrogen Sulfide Is Severely Decreased in Alzheimer Disease Brains Kimura, H (Tokyo) 84 Functional Analysis of the Presenilin Complex and ␥-Secretase Activity Tomita, T.; Takasugi, ... include partial identification of the amino acid sequence of amyloid precursor protein (APP) (1 984) , identification of amyloid precursor protein gene on chromosome 21 (1987), detection of mutations ... Most microglia in APP transgenics are not phagocytic when analyzed at the ultrastructural level [84] and appear to fit the description of being arrested at the ‘bystander microglia’ stage Consistent...
... (13–138) 0.10 Platelet count (× 109/l) 185 (48–738) 208 (40–530) 0.38 HLA-DR% 46 (8–82) 44 (11 84) 0.80 Data presented as median (range) 0.027), whereas the PC level and the APC/PC ratio did ... randomized, doubleblinded, placebo-controlled, dose-finding study Crit Care Med 2003, 31:1839- 1847 Bradley E III: A clinically based classification system for acute pancreatitis Summary of the...
... beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch EMBO Rep 2, 835 841 Sato T, Dohmae N, Qi Y, Kakuda N, Misonou H, Mitsumori R, Maruyama H, Koo EH, Haass C, Takio...
... to be associated with a number of neurodegenerative disorders, like Parkinson’s disease (Swan & Saunders-Pullman, 2013), Prion disease (Schengrund, 2010) and Huntington’s disease (Desplats et...
... critical for neuritic toxicity in a mouse model of Alzheimer’s disease Proc Natl Acad Sci USA 99, 1 0843 –1 0848 DeMattos RB, Cirrito JR, Parsadanian M, May PC, O’Dell MA, Taylor JW, Harmony JA, Aronow ... Council (2009-4567, LL; 2009-4389, LN) provided financial support References Glenner GG & Wong CW (1 984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular ... (1969) Presenile dementia and Alzheimer’s disease in mongolism Brain 92, 147–156 1402 10 Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL & Pericak-Vance...
... His Lys Arg 4 2 3 3.9917 2.1648 4.0643 6.0117 3.0265 5.0813 1.7661 1.1517 1.9935 0.96174 2.9287 2 .842 6 2.0270 0.99652 a Ile–Ile peptide bonds are known to be inefficiently hydrolyzed methods proved ... 1280 16 Walsh DM & Selkoe DJ (2007) Ab oligomers – a decade of discovery J Neurochem 101, 1172–1 184 17 Walsh DM, Hartley DM & Selkoe DJ (2003) The many faces of Ab: structures and activity Curr...
... b-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch EMBO Rep 2, 835 841 48 Kimberly, W.T., LaVoie, M.J., Ostaszewski, B.L.Ye, W., Wolfe, M.S & Selkoe, D.J (2002) Complex...
... < 0.001 and ns, not significant Inhibitors Active site IC50 Tacrine(10)9M) Edrophonium(10)6M) BW284c51 (10)9M) Peripheral site IC50 Propidium (1Q)6M) Gallamine (1Q)3M) (+)-Tubocuranine (10)6M) ... sulphate proteoglycans in cortical amyloid deposits of Alzheimer’s disease Neuroscience 51, 177– 184 Mimori Y, Nakamura S & Yukawa M (1997) Abnormalities of acetylcholinesterase in Alzheimer’s disease ... molecule confer selectivity for acetyland butyrylcholinesterase inhibitors Biochemistry 32, 12074–12 084 51 Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O & Soreq H (2006) Butyrylcholinesterase...
... overexpression of a dominant negative form of ADAM10 (Fig 4F) This mutant protein carries the E384A point mutation in the zinc-binding region of ADAM10, which is known in Drosophila melanogaster ... the amyloid protein precursor supergene family tells us about its function Neurochem Int 36, 175– 184 5817 APLP2-shedding by disintegrin-metalloproteinases Slunt HH, Von Thinakaran GKC, Lo AC, Tanzi...
... of microglia with amyloid plaques in brains of APP23 transgenic mice Am J Pathol 1999, 154:1673 -84 Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine ... interferon gamma J Clin Endocrinol Metab 1996, 81:1666-9 Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B: Costimulatory effects of interferon-gamma...
... allele significantly raised the risk of developing LOAD (OR = 1.31, 95%CI = 1.07-1.60, Power = 84. 9%) In subjects without ApoE ε4 allele, the allele and genotype distributions between LOAD patients ... August 2011 Accepted: 11 October 2011 Published: 11 October 2011 References Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney ... 1-42 and delay the cognitive decline in a mouse model of Alzheimer’s disease J Neurosci 2008, 28:5 784- 5793 Takeda K, Kaisho T, Akira S: Toll-like receptors Annu Rev Immunol 2003, 21:335-376 Yu JT,...
... the devil 15 16 Alzheimer’s Disease and Other Dementias French psychiatrist Jean Esquirol (1772– 1840 ) provided the first modern description of dementia In his classic early 19thcentury work Mental...
... 684 R Mayeux et al / Neurobiology of Aging 22 (2001) 683– 689 other APOE genotypes, individuals with ... in humans with the APOE-4 allele References [1] Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM 1999 Apolipoprotein E ... of dementia A test of the brain reserve hypothesis Psychol Med 27(6):1337– 44 [49] Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses...
... increased availability of Cu [84] Collectively, these data present a strong case for the native role of APP ⁄ Ab in regulating intracellular Cu: Cu alters APP gene expression [83 ,84] , and the APP ⁄ Ab ... Hardy JA & Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis Science 256, 184 185 45 Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB & Selkoe DJ (1999) ... electrophysiological changes and progressive neurotoxicity in cortical neurons J Neurosci 19, 8876–8 884 46 Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N & Sato K (2003) Spherical aggregates...
... 83 Walsh DM & Selkoe DJ (2007) Abeta oligomers ) a decade of discovery J Neurochem 101, 1172–1 184 84 Demuro A, Mina E, Kayed R, Milton SC, Parker I & Glabe CG (2005) Calcium dysregulation and ... and neurotoxic properties of the prion peptide PrP106–126 Biochemistry 40, 8073– 8 084 FEBS Journal 274 (2007) 3 784 3798 ª 2007 The Authors Journal compilation ª 2007 FEBS 3797 Therapy for prion ... melatonin [76], can interact with Ab and prevent its aggregation into fibrils FEBS Journal 274 (2007) 3 784 3798 ª 2007 The Authors Journal compilation ª 2007 FEBS 3787 Therapy for prion disease and AD...